MCHUGH THOMAS S
SEC insider (Form 3/4/5 filer). CIK 0001240547. Chief Financial Officer at AVADEL PHARMACEUTICALS PLC (AVDL). 4 reported Form 4/5 transactions since Sep 2024; latest on Feb 12, 2026. Located in DUBLIN 2, L2.
Companies MCHUGH THOMAS S has filed insider reports for
- AVADEL PHARMACEUTICALS PLC (AVDL): Officer, Chief Financial Officer
MCHUGH THOMAS S
CIK: 0001240547
Transaction Breakdown
Open Market Buys (P)2 (50.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (25.0%)
Compensation grants
Other (G, F, J, C, D, …)1 (25.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
AVDL
AVADEL PHARMACEUTICALS PLC
Officer
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Feb 12, 2026AVDL
AVADEL PHARMACEUTICALS PLC
DispositionDirect100.4K shares at avg. $21.00$2.1M - Mar 5, 2025AVDL
AVADEL PHARMACEUTICALS PLC
AwardDirect12.6K shares- - Dec 13, 2024AVDL
AVADEL PHARMACEUTICALS PLC
PurchaseDirect2.3K shares at avg. $10.44$24K - Dec 11, 2024AVDL
AVADEL PHARMACEUTICALS PLC
PurchaseDirect5K shares at avg. $10.49$52K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 12, 2026 | AVDL AVADEL PHARMACEUTICALS PLC | Disposition | 100,400 | $21.00 | $2,108,400 | Direct |
| Mar 5, 2025 | AVDL AVADEL PHARMACEUTICALS PLC | Award | 12,600 | - | - | Direct |
| Dec 13, 2024 | AVDL AVADEL PHARMACEUTICALS PLC | Purchase | 2,300 | $10.44 | $24,019 | Direct |
| Dec 11, 2024 | AVDL AVADEL PHARMACEUTICALS PLC | Purchase | 5,000 | $10.49 | $52,433 | Direct |
1-4 of 4 transactions